Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLC

NCT04613284 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Recombinant human endostatin (Endostar)
RADIATION: Thoracic irradiation of 50 Gy with 3DCRT or IMRT

Sponsor

Shanghai Chest Hospital

Collaborators

[object Object]